PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.190
+0.040 (3.48%)
At close: Jun 26, 2026, 4:00 PM EDT
1.210
+0.020 (1.68%)
After-hours: Jun 26, 2026, 4:13 PM EDT
PMV Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for PMV Pharmaceuticals stock have an average target of 4.50, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 278.15% from the current stock price of 1.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for PMV Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 4 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +320.17% | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $16 → $4 | Buy | Maintains | $16 → $4 | +236.13% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.17M
EPS This Year
-1.52
from -1.48
EPS Next Year
-1.09
from -1.52
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 6.5M | |
| Avg | n/a | 2.2M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 1,486.6% |
| Avg | - | 1,021.7% |
| Low | - | 556.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -1.52 | -1.09 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.